The Hydroponics Company Ltd.’s stock is under pressure after July 2018 Presentation


Recent Updates: The Hydroponics Company Ltd (ASX: THC), is a small cap company having market capitalization of $74.8 million. THC stock fell 2.50% on July 25, 2018 after the company gave presentation for July 2018. THC for Hydroponics has executed European distribution agreement, Canadian distribution agreement for expansion into BC and Due Diligence on proposed quality US acquisition is progressing. The company has recently acquired production facility in Queensland which has $16.68 million combined asset

value in Balance Sheet. The replacement value is more than $30 million. The company is targeting to export GMP pharmaceutical product in Q2 2019. Research grade GMP pharmaceutical cannabis for Australia is planned for Q1 2019. Moreover, THC has Strategic Partnership with Ascent Industries Corp, Canada. The company is in negotiation for Offtake agreement to supply pharmaceutical grade CBD product to Ascent. The Collaboration agreement is required to be formally signed for joint development of CBD and THC medicines Information exchange on medicinal cannabis markets in Australia, Canada & internationally (including cannabis extracts and their medicinal applications). Meanwhile, THC stock has fallen 11.76% in three months as on July 24, 2018.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report